Congress has the power to make obesity treatment and weight management accessible to the communities that need it.

“Early intervention would be lifestyle change, and that can be extremely helpful, especially in younger adolescents who are ...

People who switched to the experimental daily GLP-1 pill orforglipron were able to maintain their weight loss after stopping ...

The use of GLP-1 drugs to treat obesity has cause awareness of the complex medical condition to surge. But the cost of ...

Obesity is not a single disease. New research shows distinct biological phenotypes that explain why weight gain and treatment ...

Good news for people on GLP-1 therapy who hate needles: Trial data out this week shows that an experimental pill developed by ...

GLP-1 receptor agonists have captured global attention for their ability to drive weight loss and improve metabolic health.

Eli Lilly’s new obesity drug could change how millions approach weight loss. US officials warn snowbirds of 'violent crime' ...

Emil Kongshøj Larsen, Executive Vice President for International Operations at Novo Nordisk, talks to BT about India’s role ...

The perception of GLP-1s — and the people who use them — is getting better, but work still must be done to avoid stigma.

The new World Health Organization guideline supports using GLP-1 drugs for long-term obesity care, emphasizing lifestyle, ...